A recent surge in interest in T cell engagers, a type of antibody engineered to redirect the immune system’s T cells to recognize and kill cancer cells, suggests that this field is set to take off. Several biotech companies have launched specifically to develop these medicines, and big names in the industry are investing in…
cancer on The Soothsayer / page 4
The biotech industry is witnessing a surge in the development of GPCR (G protein-coupled receptor) therapies, with eight promising biotechs acquiring funding to fortify their pipelines. These biotechs are working on various GPCR-targeted drugs to address numerous diseases, including neuropathic pain, cancer, and metabolic disorders. The market for GPCR drugs is expected to grow significantly,…
Nanotechnology is transforming the healthcare industry with its potential to revolutionize drug delivery, diagnostics, and treatment of various diseases. Eight companies, including Sona Nanotech, Nanobiotix, and ARIZ Precision Medicine, are at the forefront of this revolution, developing innovative nanotechnology-based solutions for cancer treatment, autoimmune diseases, and other conditions. These companies are leveraging nanotechnology to create…
A new wave of biomimicry companies is harnessing the power of nature to develop innovative treatments for various diseases. By studying the properties of plants and animals, these companies are creating novel therapeutic targets and drugs that mimic natural protective mechanisms. From tick saliva to snake venom, these biomimicry companies are unlocking the secrets of…
The biopharma industry is witnessing a surge in investment in the immunology field, with over 10 buyouts of immunology and inflammation (I&I) drug developers this year. Several biotech companies have raised impressive funds to advance the development of their immunology-related research and development (R&D). These companies are working on innovative treatments for various diseases, including…